These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

782 related items for PubMed ID: 20304280

  • 1. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H, Wazen J, Van Ess MJ, Daugherty J, Alameda YA.
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [Abstract] [Full Text] [Related]

  • 2. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC, Minor LB.
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [Abstract] [Full Text] [Related]

  • 3. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N, Martín E, García-Tapia R.
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [Abstract] [Full Text] [Related]

  • 4. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF, Poe DS.
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [Abstract] [Full Text] [Related]

  • 5. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ, Fisher LM, Berliner K, Chung J, Green K.
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [Abstract] [Full Text] [Related]

  • 6. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E, Aidonis I, Sismanis A.
    J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
    [Abstract] [Full Text] [Related]

  • 7. Intratympanic gentamicin for the treatment of unilateral Meniere's disease.
    Kaplan DM, Nedzelski JM, Chen JM, Shipp DB.
    Laryngoscope; 2000 Aug; 110(8):1298-305. PubMed ID: 10942130
    [Abstract] [Full Text] [Related]

  • 8. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V, Carner M, Colletti L.
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [Abstract] [Full Text] [Related]

  • 9. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA, Chen DA, Arriaga MA.
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [Abstract] [Full Text] [Related]

  • 10. Intratympanic gentamicin therapy for Ménière's disease.
    Hirsch BE, Kamerer DB.
    Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951
    [Abstract] [Full Text] [Related]

  • 11. Intratympanic gentamicin instillation as treatment of unilateral Menière's disease: update of an ongoing study.
    Nedzelski JM, Chiong CM, Fradet G, Schessel DA, Bryce GE, Pfleiderer AG.
    Am J Otol; 1993 May; 14(3):278-82. PubMed ID: 8372926
    [Abstract] [Full Text] [Related]

  • 12. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
    Smith WK, Sandooram D, Prinsley PR.
    J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921
    [Abstract] [Full Text] [Related]

  • 13. Transtympanic gentamicin treatment in Meniere's disease: a preliminary report.
    Kasemsuwan L, Jariengprasert C, Chaturapatranont S.
    J Med Assoc Thai; 2006 Jul; 89(7):979-85. PubMed ID: 16881430
    [Abstract] [Full Text] [Related]

  • 14. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
    Hsieh LC, Lin HC, Tsai HT, Ko YC, Shu MT, Lin LH.
    Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
    [Abstract] [Full Text] [Related]

  • 15. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
    Akkuzu B, Ozgirgin N, Ozlüoğlu LN.
    Kulak Burun Bogaz Ihtis Derg; 2006 Dec; 16(5):193-9. PubMed ID: 17124437
    [Abstract] [Full Text] [Related]

  • 16. Intratympanic gentamicin for Menière's disease: a meta-analysis.
    Cohen-Kerem R, Kisilevsky V, Einarson TR, Kozer E, Koren G, Rutka JA.
    Laryngoscope; 2004 Dec; 114(12):2085-91. PubMed ID: 15564826
    [Abstract] [Full Text] [Related]

  • 17. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M, Kitahara T, Fukushima M, Nakagawa A, Masumura C, Sasaki T, Kizawa K, Kubo T.
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [Abstract] [Full Text] [Related]

  • 18. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
    Kaplan DM, Hehar SS, Bance ML, Rutka JA.
    Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
    [Abstract] [Full Text] [Related]

  • 19. Intratympanic gentamicin therapy for intractable Ménière's disease.
    De Beer L, Stokroos R, Kingma H.
    Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
    [Abstract] [Full Text] [Related]

  • 20. Intratympanic gentamicin for Ménière's disease: effect on quality of life as assessed by Glasgow benefit inventory.
    Banerjee AS, Johnson IJ.
    J Laryngol Otol; 2006 Oct; 120(10):827-31. PubMed ID: 16707038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.